Len Walt, Vice President, Head of Medical Affairs, Sobi in North America, discusses his company’s clinical trial testing anakinra in Still’s disease, a rare inflammatory disorder.
Still’s disease, a disorder featuring inflammation, is characterized by high spiking fevers, salmon-colored rash that comes and goes, and arthritis. Still’s disease is also referred to as systemic-onset juvenile idiopathic arthritis. Still’s disease was first described in children, but it is now known to occur, much less commonly, in adults (in whom it is referred to as adult-onset Still’s disease or AOSD). Still’s disease is named after the English physician Sir George F. Still (1861-1941).